RTI Biologics is one of the leaders in tissue-based innovations that are used to repair and promote the natural healing of human bone and other tissues. The company processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue to produce allograft implants. Surgeons then implant these allografts to repair a wide variety of bone and other tissue defects, including spinal vertebrae repair, musculoskeletal reconstruction, fracture repair, periodontal repair, urinary incontinence and heart valve disorders. RTI Biologics patented BioCleanse tissue sterilization process eliminates bacteria, fungi, spores and viruses from the tissue. The sterilization process also removes all blood, fats, lipids and cellular debris from the tissue. The company continues researching new ways to use allografts in the natural healing of patients. RTI Biologics is headquartered in Alachua, Fla., with a cardiovascular branch in Birmingham, Ala.